Flutemetamol (18F)

Flutemetamol (18F)
Systematic (IUPAC) name
2-[3-(18F)Fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol
Clinical data
Trade names Vizamyl
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy
category
  • US: C (Risk not ruled out)
Legal status
Routes of
administration
Intravenous
Identifiers
ATC code V09AX04
PubChem CID 15950376
ChemSpider 13092196
UNII 0F3M7032P5
ChEBI CHEBI:76611
Chemical data
Formula C14H1118FN2OS
Molar mass 273.316 g/mol

Flutemetamol (18F) (trade name Vizamyl, by GE Healthcare) is a PET scanning radiopharmaceutical containing the radionuclide fluorine-18, used as a diagnostic tool for Alzheimer's disease.[1]

Mechanism of action

After the substance is given intravenously, it accumulates in beta amyloid plaques in the patient's brain, which thus become visible via positron emission tomography (PET).[1]

References

  1. 1 2 H. Spreitzer (18 August 2014). "Neue Wirkstoffe – Flutemetamol". Österreichische Apothekerzeitung (in German) (17/2014): 43.
This article is issued from Wikipedia - version of the Sunday, September 21, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.